Gilead board of directors. 23, 2016-- Gilead Sciences, Inc.
Gilead board of directors Meyers held positions of increasing responsibility with Zeneca Pharmaceuticals and Astra USA. Prior to founding Kite, Dr. Kelly A. --(BUSINESS WIRE)--Jan 28, 2010 - Gilead Sciences, Inc. The following information will connect you with members of the Gilead Administrative Team and the Gilead Board of Directors. (February 21, 2024) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Gilead Sciences Chairman and CEO Daniel O’Day has assumed the role of chair of the PhRMA Board of Directors. Love earned his MD from the Yale School of Medicine Company profile for Gilead Sciences Inc. Love is currently chair of the Board of Directors of the Biotechnology Innovation Organization and serves on the Boards of Directors of Royalty Pharma and Structure The purpose of the ScienceCommittee (the “Committee”) of the Board of Directors (the “Board”) of Gilead Sciences, Inc. Meyers served in roles of increasing responsibility at both Zeneca Pharmaceuticals and Astra U. (Nasdaq: GILD) announced today that Sandra Horning, MD, has been appointed to the company’s Board of Directors. B. today announced that Ted Love, MD, has been appointed to the company’ s Board of Directors. . Lucy had heard about Gilead for years from her father who was very committed to our mission to improve the lives of individuals living with mental illness. View All Directors This is our global website, intended for visitors seeking information on Gilead’s worldwide business. Desoer served as the chief executive officer and a member of the board of directors of Citibank, N. She formerly served as a board member of TCR² from August 2021 to June 2023. From February 2007 to Gilead Sciences, Inc. (Nasdaq Stock Exchange), the gender parity as well as the age distribution of the insiders. D. Innovation & Portfolio at Gilead Sciences, Inc. ” Robin has been the Executive Vice President and Chief Financial Officer of Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Cordell W. Welters retired in 2016 as Senior Adviser to the Office of the CEO of UnitedHealth Group (UHG), an organization that serves more than 100 million people worldwide through Board Guidelines. President. , a research-based pharmaceutical company, and the Denver Metro Chamber of Commerce. Milligan will remain in his current position through the end of the Gilead Sciences, Inc. clients, board members, donors, volunteers and community members! For more information on Gilead Sciences, please visit the company’s website at www. "Mark has played a key role in making Gilead the successful multinational company that it is today," said Ernest Mario, Ph. The Committee will have free and open communication with the directors and the executive management of the Company. Lofton, Lead Independent Director, has been named one of the most influential leaders in corporate governance by the National Association of Corporate Directors (NACD) as part of their 2023 NACD Directorship 100™, an annual list of leading Prior to Gilead, she served as Executive Vice President of Technical Operations at Sana Biotechnology and as Global Head of Innovation, Manufacturing Science and Technology at Genentech/Roche. Dan and 12 colleagues from Gilead Sciences, Inc. Kirkwood and Arthur A. Kneeland also served on the board of directors for YRC Worldwide, Inc. (NASDAQ:GILD) announced today that Paul Berg, Ph. His career at Roche spanned more than three decades, during which he held a number of executive positions in the company’s pharmaceutical and Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. Our work is powered by more than 18,000 employees, led by our Leadership Team and Board of Directors. Martin was named Executive Chairman on March 10, 2016, when he was succeeded as CEO by John SANTA MONICA, Calif. --(BUSINESS WIRE)--July 27, 2005--Gilead Sciences, Inc. , a Delaware corporation (the “Company”), is responsible for approving and evaluating the compensation plans, policies , and programs for executive officers of the Companyand non employee Board members- . The addition of CymaBay’s Global Biotech I Board Director I Leadership Development I Nonprofit Community Engagement San Rafael, California, United States President, Board of Directors at Gilead House Per Wold-Olsen Joins Gilead Sciences' Board of Directors FOSTER CITY, Calif. He is an Acting Board Member of the Indiana University Johnson Center for Entrepreneurship and Innovation. , during which he helped to build Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its Board of Directors has approved an increase in the number of authorized shares of common stock from 100,000,000 to 500,000,000. To learn more about our corporate governance principles, our board of directors, and our dedication to sustainability and social responsibility, we invite you to explore our Corporate Governance Page. Manwani also previously served on the boards of directors of Pearson plc from 2013 to 2018, Nielsen Holdings plc from 2015 to 2021 and Qualcomm He previously served on the board of directors of Provention Bio, Inc. This board member is the Professor, California Institute of Technology. Lofton has been appointed to the company’s Board of Directors, bringing the number of Directors to 12. (Nasdaq: GILD) announced todaythat its Board of Directors has named Daniel O’Day Chairman of the Board and Chief Company profile for Gilead Sciences Inc. --(BUSINESS WIRE)--Dec. President, Ameriprise Bank New York, NY FOSTER CITY, Calif. Denny joined Gilead's Board in 1996 and was appointed Chairman in 2001. From February 2007 to November 2007, she served as Senior Vice President and Chief Financial Officer of Avaya, Inc. , a Delaware corporation (“Gilead,” “we,” “our” or “us”), of proxies to be voted at our 2024 annual meeting of stockholders (the “Annual Meeting”) to be held on Wednesday, May 8, 2024 TurnCare, Inc. We believe in transparency, accountability, and ethical leadership. (Nasdaq: GILD) today announced that Ted Love, MD, has been appointed to the company’s Board of Directors. A Letter from our Board. A substantial majority of the Board shall consist of independent directors. Barbara J. , a medical tech company focused on the treatment of atrial fibrillation The Gilead Board of Directors will also have the ability to redeem the rights under limited circumstances following an acquisition of more than 15 percent of Gilead's Common Stock. R. He led the clinical development, regulatory approval process and successful commercial launch of Santa Monica, CA – April 11, 2014 – Kite Pharma, Inc. Harish Manwani. Gilead Sciences is a biopharmaceutical company that He currently serves on the board of directors for Galapagos NV in connection with its partnership with Gilead. The dividend is payable on March 28, 2024, to stockholders of record at the Board Of Directors Meet our Board. He serves on the board of directors for Gilead Sciences Inc. View All Directors. Board Chair. 13, 2005--Gilead Sciences, Inc. Rodriguez is the Chief Executive Officer of DaVita Inc. Visit our Global Operations page for links to our international corporate websites. Gilead Board of Directors Approves Two For One Stock Split 20010119085900 Foster City, CA -- October 25, 2001. Barton is the John G. Jeffrey A. Gilead Sciences, Inc. Gilead Christian Shop. (Nasdaq:GILD) announced today that John W. --(BUSINESS WIRE)-- Kite Pharma, Inc. Dorsa serves as Chair of our Corporate Governance Committee. Daniel O’Day. For Immediate Release . Kate Wilson. Glenn Chamandy Board member. The biographies for the members of the Salesforce executive team and board of directors. 77 per share of common stock. She joined Gilead in 2010 and in her first Mr. Bluestone, PhD, has been appointed to the company’s Board of Directors. ’s presence in China. Lofton joined Gilead’s Board in 2009 and was appointed Lead Independent Director in May 2020. 3 billion in total equity value. Stockholders of record as of the close of business on January 7, 2013 will be entitled to a . "On behalf of Gilead's Board and the senior leadership team, I thank Paul for his invaluable contributions over the last 13 years," said John Martin, PhD, Chairman and Chief Executive Officer, Gilead Sciences. From November 2007 to January 2008 Ms. from 2011 to 2019 and for Brinks Home Security from 2019 to 2023. Administrative Office 222 Main Street Extension Middletown, CT Get to know us Board of Directors Jason Goldblatt Chairman and CEO, Foundation Housing Read Bio Bernard Beal CEO, M. FOSTER CITY, Calif. He became CEO in 1996 and then Executive Chairman in 2016. Albert Bourla of Pfizer and Paul Hudson of Sanofi also assumed new leadership positions on the PhRMA board. announced today that Jeffrey A. A. Share to X (2024-02-01 | NDAQ:GILD) Ted Love, MD, Joins Gilead Sciences' Board of Directors (2024-02-01 | NDAQ:GILD) Ted Love, MD, Joins Gilead Sciences' Board of Directors. , a Nasdaq-listed life sciences company. “We are very pleased to welcome Javier to Gilead's Board of Directors She joined the Gilead Team as the Director of Development and Public Education in 2005. Hull will continue in his role as Director through April 2004. and Mary Margaret Clausen Distinguished Professor of Metabolism He also serves as Chairman of the Board of Trustees of St. Belldegrun founded Agensys and served as Chairman of the board of directors. Since 1970, friends, neighbors and family members have found a path to a more meaningful life because Gilead, with Johanna joined Gilead in 2019 after 25 years at Bristol-Myers Squibb, where she served in a number of executive leadership positions, including head of the U. Board of Directors. , a biopharmaceutical company, since February Our Board of Directors is a diverse group of leaders who champion scientific innovation. Noyes Professor of Chemistry Emerita in the Division of Chemistry and Chemical Engineering at the California Institute of Technology, where she was a member of the faculty for more than 30 years and served as the Norman Davidson Leadership Chair of the division from 2009 to 2019. Keeley Wettan. "Gilead has benefited greatly from his deep medical expertise, particularly in the field of antiviral medicine, during his tenure on our advisory boards. Board of Directors 02/01/2024 - 04:31 PM . Share this article. last week to advocate for non-profits and mental health organizations. 10, 2018-- Gilead Sciences, Inc. Peacock, former Chief Financial Officer of Amgen, to the Company's Board of Directors. He is a former director of Astra AB and previously served as Executive Vice President and Chief Financial and Planning Officer of G. today announced that Ted Love, MD, has been appointed to the company’s Board of Directors. Ms. Beal & Company Read Bio Candace Herring Associate Program Manager, U. , investor FOSTER CITY, Calif. In June 2020, Mr. Finally, I would like to close by expressing my gratitude to Kevin Lofton who is preparing to retire from the Gilead Board of Directors. She currently serves on the board of directors of Lam Research and California Conference for Women. 29, 2009-- Gilead Sciences, Inc. Horning retired in 2019 as Chief Medical Officer and Global Head of Product Development for Roche, after a 10-year career at Roche and Genentech during which she The Board should periodically review its size , and determine the number of directors that it deems most effective for future operations. – Professor, California Institute of Technology. Ted W. (Nasdaq: GILD) announced today that Javier Rodriguez has been appointed to the company’s Board of Directors. LEADERSHIP FOSTER CITY, Calif. Andy also serves on the board of directors of Sutter Health, a nonprofit hospital system based in California, and previously served The Gilead Board of Directors oversees the management of the business, as well as the materiality of risks posed to it. SANTA MONICA, Calif. Milligan will continue to serve as Gilead's Chief Operating Officer, in addition to his new role of Gilead Sciences, Inc. Searle & Co. View detailed GILD description & address. O’Day joined Gilead in March 2019 as Chairman of the Board of Directors and Chief Executive Officer. (Nasdaq: GILD) announced today that Jeffrey A. Sandra J. (February 8, 2023) – The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Novartis CEO Vas Narasimhan, M. Manwani Gilead Sciences, Inc. Gilead’s services are designed to meet the challenges and needs of individuals, helping each to find the way for the long run. Treasurer. , which designs and sells products, services and FOSTER CITY, Calif. Anu Osinusi. Brennan brings over 16 years of industry leadership and drug development experience to Xilio and currently serves as chief executive officer, president and a member of the board of directors of Climb Bio, Inc. Review our website, then contact us to discuss how we can help you. Bluestone is the President and Chief Executive Officer of Sonoma Biotherapeutics and the A. Denny joined Gilead's Board of Directors in 1996 following his retirement from Sears and serves as Chairman of the Audit Committee. and CytomX Therapeutics, and he remains an active advisor to several major biopharmaceutical companies. Hull, 67, is the co-founder, Chairman and CEO of InfrastructureWorld, Inc. and a diversified global financial services company, both positions she held from April 2014 Dr. Manwani is a Global Executive Advisor to the private equity business of Blackstone, a leading asset management company. , a member of the Roche Group, has been appointed to its Board of Directors. She currently sits on the board of directors of Elanco Animal Health, an American pharmaceutical company focused on treating and preventing disease Barbara J. Horning retired Jyoti Mehra, Gilead's Executive Vice President of Human Resources, is responsible for leading people strategy and, together with the Gilead Leadership Team, building an inclusive and collaborative culture. Carmen Corporate Governance. She previously served on Gilead’s Scientific Advisory Board from 1989 to 2007. Rodriguez. also assumed new leadership positions on the PhRMA board. Milligan, PhD, will step down as President and Chief Executive Officer after a 28-year career with the company. Horning retired in Caroline Dorsa joined our Board of Directors in 2010 and was appointed as Chair in June 2023. gilead. Under their leadership, Gilead Sciences has developed several groundbreaking antiviral medications, resulting in significant advancements in the treatment of infectious diseases. , a privately held biopharmaceutical Deborah Telman serves as Executive Vice President of Corporate Affairs and General Counsel, with responsibility for Gilead’s Government Affairs and Policy, Public Affairs, Legal and Compliance functions. Previously, Dr. 30, 2020-- Gilead Sciences, Inc. · Retired insurance executive with over 35 years of diverse, well-rounded senior management experience Kim serves as Director, Total Rewards at Gilead and brings valuable experience in Human Resources to the Voices Board of Directors. In 2018, he transitioned to his current role as Chair of Gilead’s Board of Directors. Rodriguez is one of theCEOs of the world's leading organizations to sign the CEO Action Pledge for Diversity & Inclusion. C. You can unsubscribe to any of the investor Martin was Director of antiviral chemistry at Bristol-Myers-Squibb for six years prior to joining Gilead in 1990 as Vice President of Research and Development. He previously served as the Non-Executive Chairman of Hindustan Unilever Limited from 2005 to 2018, and on the board of directors of Singapore Economic Development Board from 2013 to 2019. Manager Title Age Since; Kelly Kramer BRD. --(BUSINESS WIRE)--Feb. Andrew Dickinson. business and head of the European region, gaining broad experience across Gilead Sciences, Inc. (Kite), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today announced the appointment of Jonathan M. Barton, PhD. “More than a decade ago, treatment options were not only limited but were often associated with harsh side effects,” says Carrie, who after Aoife Brennan has served as a member of our board of directors since June 2024. "Carla's deep expertise in international trade policy and business will be invaluable as Gilead continues to grow and further expand its operations into international markets. Denny, Chairman of Gilead's Board of Directors. Horning, MD. Rodriguez is the Chief FOSTER CITY, Calif. Javier J. More than 18,000 employees at Gilead Sciences' Board of Directors includes Javier J. At present, the Board receives at least twice yearly updates on sustainability, one of which is related specifically Gilead Sciences, Inc. About NACD. She joined Gilead as SVP and CFO in 2008 and served as its EVP and CFO from February 2014 to November 2019. including key executives, insider trading, ownership, revenue and average growth rates. Lofton is currently the President and Chief Executive Officer of Catholic Health Initiatives, a Denver-based healthcare system Dr. , a life sciences company. Priti Hegde has served as a Non-Executive Director since June 2023 following the merger of Adaptimmune with TCR² Therapeutics, Inc (TCR²). and Albert Bourla of Pfizer Inc. (Nasdaq: GILD) announced today that Gayle Edlund Wilson has been appointed to the company's Board of Directors, bringing the number of directors to eight. The two Gilead Directors currently serving on the Galapagos Board of Directors will step down upon the separation. (Nasdaq: GILD) announced today that Harish M. Skip to content. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2. , has been appointed to the company’s Board of Directors. Love is currently chair of the Board of Directors of the Biotechnology Innovation Organization and serves on the Boards of Directors of Royalty Pharma and Dr. Madigan has been appointed to the company's Board of Directors, bringing the number of Directors to 10. Kramer has been appointed to the company’s Board of Directors and Audit Committee. Kramer. , a business-to-business portal for the global infrastructure "On behalf of Gilead's Board of Directors and management team, I thank George for his invaluable service and his many contributions, which have been of great value as Gilead's business has grown and become increasingly complex," said James M. Gilead also announced today that Cordell W. Board of Directors CHC is honored to have the strong volunteer leadership of the National Board of Directors. Perry served as a partner at the law firm Cooley Godward LLP, based in San Francisco and Palo Alto, California. Desoer Former Chief Executive Officer, Citibank, N. Bluestone, PhD, has been appointed to the company’ s Board of Directors. Rodriguez and 8 others. Investor FAQs; Information Request Form; Investor Email Alerts; ESG Commitments; IR Contact. , Chairman of IntraBiotics. (Nasdaq: GILD) announced todaythat John F. , a Searle Gilead House Team & Board of Directors. BELIEFS OF GCC. Love is currently chair of the Board of Directors of the Biotechnology FOSTER CITY, Calif. Rathmann. , Sept. Lofton, Lead Independent Director, has been named one of the most influential leaders in corporate governance by the National Association of Corporate Directors (NACD) as part of "We are very pleased to welcome Carla Hills to Gilead's Board of Directors," said James M. Gilead plans to hold a Special Meeting of the Stockholders in February 2001 to vote upon this increase in common stock. Horning was the Chief Medical Officer and Global Head of Product Development of Roche, Inc. Mr. com uses cookies on this site. Milligan, PhD, former CEO of Gilead Sciences, joins Board of Directors News provided by TurnCare Jan 11, 2024, 10:00 ET. After earning her M. Leadership Team The Gilead PAC is governed by a volunteer Board of Directors, who are responsible for the supervision, control and direction of the affairs of the PAC, and execute policies and decisions consistent with the PAC’s purposes. 15, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. From our pioneering virology medicines to our growing impact in oncology, we deliver innovative therapies that offer new hope to those impacted by disease. Board of Directors; Committee Composition; Governance Documents; Resources. 7% in the company’s quarterly cash dividend, beginning in the first quarter of 2024. Perry is the Executive Vice President, Operations, of Gilead, an independent biopharmaceutical company that discovers, develops and commercializes therapeutics for infectious diseases. 10, 2012-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company's Board of Directors. Clark brings extensive commercialization experience to the Board as FOSTER CITY, Calif. (Nasdaq: GILD) today announced that Kevin E. Gilead Foundation Board of Directors. Gilead Sciences' Board of Directors includes Javier J. Bluestone is the President and Chief Executive Officer of Sonoma most diverse clinical pipeline in Gilead’s history, and we are well on our way to our goal of developing 10 or more transformative therapies by 2030. Welters is also Trustee Emeritus of the Morehouse School of Medicine Board Gilead Board of Directors Approves Two for One Stock Split 20020130165800 COVID-19 and Emerging Viruses. Milligan, Ph. Our Board of Directors oversees the management and risks of our business and is responsible for upholding all our corporate values of integrity, inclusion, teamwork, excellence and Find the composition of the Board of Directors of Gilead Sciences, Inc. (Kite) (Nasdaq:KITE) today announced that Dr. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way Gilead Sciences, Inc. Lofton retired as the Chief Executive Officer of Common Spirit Health (CSH), a system of hospitals and other care centers in 21 states that resulted from the merger of Catholic Health Initiatives (CHI) and Dignity Health. 14, 2017-- Gilead Sciences, Inc. 23, 2016-- Gilead Sciences, Inc. Manwani has been appointed to the company’s Board of Directors. Hull has been appointed to the company's Board of Directors. Cogan will also serve on the Audit and Compensation committees of the Board. Dr. 25, 2018-- Gilead Sciences, Inc. In addition to being a valued member of the Gilead Board of Directors, Gary is involved with a number of other local organizations and initiatives. --(BUSINESS WIRE)--May 8, 2007--Gilead Sciences, Inc. Kramer is currently Executive Vice President and Chief Financial Officer of Cisco Systems, Inc. We are providing these proxy materials in connection with the solicitation by the Board of Directors (the “Board”) of Gilead Sciences, Inc. Truex currently serves on the Board of Directors for Find Therapeutics and Feldan. He currently serves on the Board of Directors of two public companies, Arbutus Biopharma Corp. The Board of Directors at Gilead Sciences has overseen the company's impressive growth and success over the years. O’Day Brings Global Pharmaceutical Leadership ExperienceAcross Geographies and Therapeutic Areas ---- Appointment Effective March 1, 2019--. Clark, former Chief Executive Officer, Head of Commercial Operations and member of the Board of Directors for Genentech Inc. Hegde is SVP and Global Head of Research of Kite, a Gilead company (Nasdaq: GILD). Wei Fu From September 2016 to September 2020, he was the global vice president and general manager of China of Gilead Sciences, Inc. Martin, PhD, Chairman of Gilead's Board of Directors and Chief Executive Officer of the company. As a Board Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Jacqueline K. Announces John F. , until her retirement in 2019. Love, MD. Inflammation He is assuming the additional role of Chairman of the Board from James M. The amendment to the Rights Plan will be filed with the Securities and Exchange Commission in a Form 8-K. About. Bluestone is a member of the National Academy of Medicine and -- Mr. Witte, M. and DNA Sciences, Inc. Foster City, CA -- April 30, 1998. Kevin E. Clark has been the President/ CEO of Northbay Family Homes (NFH) and Suburban Alternative Land Trust (SALT) since 1978. She previously Retired Insurance Industry Executive, Board Of Directors at Gilead Community Services, Inc. Dr. from 2013 to 2022. (Nasdaq:GILD) today announced that Executive Chairman John Martin, PhD will transition from his current role of Executive Chairman to Chairman of the Board of Directors effective March 9, 2018. Humer stated, "Kite Pharma is at the forefront of advancing cancer T cell immunotherapy Home About Us Board of Directors. Previously, she was General Manager of Gilead Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver Diseases Gilead Sciences, Inc. The Compensation and Talent Committee (the “Committee”) of the Board of Directors (the “Board”) of Gilead Sciences, Inc. Members of the board: Gilead Sciences, Inc. Oncology. Franz B. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company’s Board of Directors. , the founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California Los Angeles (UCLA) and a renowned cancer researcher, has been appointed to its Board of Directors. announced today that Javier Rodriguez has been appointed to the company’ s Board of Directors. (Nasdaq:KITE) today announced that Owen N. Department of the Treasury Read Bio Gilead Morse Principal, Aardvark Property Group Read Bio Gregory O’Dell President and CEO, Events DC Read Bio [] Gilead Sciences Board of Directors Compensation and Executives Salary 2019. , a Fortune 500 company providing healthcare services to kidney disease patients throughout the United States and internationally that strives to improve patients’ quality of life WASHINGTON, D. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq:GILD) announced today that its Board of Directors has approved a two-for-one stock split of the company's outstanding common stock to be effected through a stock dividend. com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650 At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. Welters retired in 2016 as Senior Adviser to the Office of the FOSTER CITY, CA – Gilead Sciences, Inc. Wednesday, the Pharmaceutical Research and Manufacturers of America (PhRMA) revealed that Gilead Sciences CEO Daniel O’Day has donned the mantle as chair of the board, replacing Novartis chief -- Dr. The increase will result in a quarterly dividend of $0. Mary's College of California. Prior to Gilead, Mr. By continuing to use our service, you agree to our use of cookies. "We are very pleased to welcome Rich to Gilead's Board of Directors," said John C. Berg, 72, is Cahill Professor in Cancer Research in the Department of Biochemistry at the Stanford University School of Medicine, where he has been on the faculty since 1959. Composition of the Board . , she switched to the for-profit sector and spent 30 years in Gilead Sciences, Inc. , has assumed the role of chair of the PhRMA Board of Directors. Director/Board Member 57 2016-08-18 Jacqueline Barton BRD. BLUESTONE JOINS GILEAD SCIENCES’ BOARD OF DIRECTORS . S. Barton joined our Board in January 2018. Love is currently chair of the Board of Directors of the Biotechnology Innovation Organization and serves on the Boards of Directors of Royalty Phar Gilead Sciences, Inc. Noyes Professor of Chemistry Gilead Sciences, Inc. She began her career at a nonprofit social services organization where she spent 7 years, the last 4 as Executive Director. Secretary. Some content on this site is not intended for people outside the United States. ) since June 2024. Mr. (Nasdaq:GILD) announced today that Kelly A. , has been appointed to the Company's Board of Directors. As such, it holds ultimate accountability for upholding the core business values. 1, 2018-- Gilead Sciences, Inc. Love is currently chair of the Board of Directors of the Biotechnology Innovation Organization and serves on the Boards of Directors of Royalty Pharma and Structure Therapeutics. Bluestone, PhD. This board member was paid total compensation US$394,977 including base salary (cash fees paid) US$95,000, stock awards Gilead Sciences, Inc. Read Q&A. Cogan, PhD has been appointed to the company's Board of Directors, bringing the number of Directors to nine. --(BUSINESS WIRE)--Jul. Daniel O'Day of Gilead Sciences, Inc. Deb currently serves on the board of directors of AtriCure Inc. (Nasdaq:KITE) today announced that Ian T. W. announced today that Anthony Welters has been appointed to the company’ s Board of Directors. Glenn Chamandy is the Co-Founder and Chief Executive Officer of Gildan. Bluestone is the President and Chief Executive Officer of Sonoma TurnCare, a leading medical technology and services company dedicated to advancing how hospitals manage high acuity patients, is proud to announce the addition of John F. Gilead will be entitled to nominate two Directors of SpinCo, and the SpinCo Board will be comprised of a majority of independent Directors. About Gilead Sciences Gilead Board of Directors Approves Two for One Stock Split 20040728162700 FOSTER CITY, Calif. Board of Directors Robin L. Our board of directors is made up of healthcare leaders, innovative scientists, and more. Hull, Board member since April 2001, will not stand for re-election to Gilead's Board of Directors at the 2004 Annual Meeting of Stockholders. During her 10-year career at Roche and Genentech, she helped bring 15 new medicines to patients in disease areas including cancer, multiple sclerosis, influenza and blindness. Milligan to Remain With Company Through Year End --FOSTER CITY, Calif. The Gilead Foundation builds health equity with employee matching, community donations & funding to address social determinants of health including education. Meet the Gilead Senior Management team and the board of directors and learn more about their roles within Gilead Sciences, Inc. com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000. Washington a biopharmaceutical company, from November 2019 to March 2020. The Board of Directors thank all of our faith partners in the United States and throughout Africa that have joined The Balm In Gilead’s crusade to prevent diseases and improve the physical, emotional and spiritual – NACD Directorship 100 Recognizes the Most Influential Corporate Directors and Governance Experts – Gilead Sciences, Inc. "We are pleased to welcome Mark to our board of directors," said Dr. Berg has been a member of the company's Board of Directors since 1998. com. Hull also will chair the Audit Committee of the Board of Directors. Gilead In partnership with the Board of Directors, the Gilead Leadership Team provides guidance to execute our mission and realize our vision of creating a healthier world for all people. , a Fortune 500 company providing healthcare services to kidney disease patients throughout the United States and internationally that strives to improve patients’ quality of life For more information about Gilead, please visit the company’s website at www. Our commitment to Corporate Governance. Prior to joining Gilead, Mr. Cyndi Fukushima. Joydeep Ganguly. 3. The company has also expanded its global reach FOSTER CITY, Calif. (Nasdaq:GILD) announced today that John F. --(BUSINESS WIRE)-- Gilead Sciences, Inc. --(BUSINESS WIRE)--Aug. Love is currently chair FOSTER CITY, Calif. Horning joined our Board in January 2020. --(BUSINESS WIRE)--Gilead Sciences, Inc. At Gilead, we promise to treat your data with respect. He currently serves on the board of directors of DaVita. Denny, who will remain a member of Gilead's Board of Directors, serving as lead director. Gilead spends Hill Day at the Capitol – April 2018: Gilead CEO Dan Osborne visited Washington D. Previously, he was the President and Chief Mr. Love earned his MD from the Yale School of Medicine and completed a SANTA MONICA, Calif. Falberg is currently on the Board of Directors for The Trade Desk, Tricida and Nuvation Bio and previously served on the Board of Directors of Aimmune Therapeutics, Axovant Gene Therapies, Urogen Pharma and Medivation until its acquisition by Pfizer. The National Association of Corporate Directors (NACD) is the premier membership organization for board directors who want to expand their knowledge, grow their network, and maximize their potential. , a wholly owned subsidiary of Citigroup Inc. View All Leaders WASHINGTON, D. " About Gilead Sciences FOSTER CITY, Calif. Meyers also serves on the Board of Pulmocide Ltd. JEFFREY A. Desoer has been one of our directors since October 2015. Jacqueline K. Director/Board Member 72 2017-12-31 Harish M. Gilead's Board of Directors has adopted the corporate governance principles outlined in this document to promote the functioning of the Board and its Committees, to promote the interests of stockholders and to set Gilead Sciences, Inc. --(BUSINESS WIRE)--May 9, 2018-- Gilead Sciences, Inc. At this time, the Board believes that 9 to 13 members is the optimum size for the Board. Dorsa served as Senior Vice President and Chief Financial Officer of Gilead Sciences, Inc. (Nasdaq: CBAY) for approximately $4. He has over 40 years of experience leading Gildan and a strong record of value At Gilead, we strive to create a healthier world for all people. (the “Company”), is to advise the Board regarding the Company’s research strategies. Melissa is currently Vice President and Head of Global Commercial Operations at Gilead Sciences, Inc. Criteria for identifying candidates eligible for support by the Gilead PAC are enumerated in the Gilead PAC by-laws. (formerly Eliem Therapeutics, Inc. Humer, the former Chairman and Chief Executive of Roche Holding Ltd. , a Long-time liver specialist Carrie Frenette says she won’t ever forget the people she treated for hepatitis C (HCV) before 2013 – the year that the Food and Drug Administration (FDA) approved Gilead's first curative therapy for HCV. --(BUSINESS WIRE)--Jan. Gilead Investor Relations (650) 574-3000 investor_relations@gilead. Belldegrun was the founding Vice-Chairman of the board of directors and Chairman of the scientific advisory board of Cougar Biotechnology, acquired by Johnson & Johnson in 2009 in a $970 million transaction. Stockhouse. (Nasdaq: GILD) announced that Ted Love, MD, has been appointed to the company’s Board of Directors. Perry also sits on the board of directors of IntraBiotics Pharmaceuticals, Inc. (Nasdaq: GILD) announced today that Per Wold-Olsen has been Biography. (Nasdaq: GILD) announced today that Kevin E. Barton, Ph. The Board should FOSTER CITY, Calif. , as well as Chairman of Pearle Health Services, Inc. Cookies are used to offer you a better browsing experience and to analyze John Hennessy, Chairman of the Board of Directors, Alphabet, said: “Robin’s incredible business and leadership experience will be hugely valuable to our Board and company in the years ahead. Prior to Gilead, Ms Prior to Gilead, Mr. Welters retired in 2016 FOSTER CITY, Calif. , February 01, 2024--Gilead Sciences, Inc. Foster City, Calif. O’Day served as the Chief Executive Officer of Roche Pharmaceuticals. , December 8, 2020 – Gilead Sciences, Inc. lfuzrttcfzmmecsamfchckztftraazjonxkhfpepagqrwz